{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-096984","form_type":"8-K","ticker":"ITRMF","cik":"0001659323","company_name":"Iterum Therapeutics plc","filed_at":"2025-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.581367+00:00","generated_at":"2026-05-18T05:46:06.605809+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Iterum sets 2025 AGM for Sept 10; shareholder proposals due July 28","bullets":["Annual General Meeting scheduled for September 10, 2025.","Record date for voting eligibility is July 15, 2025.","Deadline for shareholder proposals under Rule 14a-8 is July 28, 2025.","Deadline for director nominations and other proposals is July 28, 2025.","Meeting is more than 30 days later than prior year's AGM, triggering new deadlines."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-096984","json":"https://secwatch.observer/filing/0000950170-25-096984.json","markdown":"https://secwatch.observer/filing/0000950170-25-096984.md","text":"https://secwatch.observer/filing/0000950170-25-096984.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1659323/000095017025096984/0000950170-25-096984-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1659323/000095017025096984/itrm-20250717.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:46:06.605809+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}